Preclinical safety, pharmacokinetics, pharmacodynamics, and biodistribution studies with Ad35K++ protein: a novel rituximab cotherapeutic - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Molecular Therapy - Methods and Clinical Development Année : 2016

Preclinical safety, pharmacokinetics, pharmacodynamics, and biodistribution studies with Ad35K++ protein: a novel rituximab cotherapeutic

Domaines

Immunologie

Dates et versions

hal-02322334 , version 1 (21-10-2019)

Identifiants

Citer

Maximilian Richter, Roma Yumul, Kamola Saydaminova, Hongjie Wang, Michael Gough, et al.. Preclinical safety, pharmacokinetics, pharmacodynamics, and biodistribution studies with Ad35K++ protein: a novel rituximab cotherapeutic. Molecular Therapy - Methods and Clinical Development, 2016, 3, pp.16013. ⟨10.1038/mtm.2016.13⟩. ⟨hal-02322334⟩
4 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More